Review of calcium-sulphate-based ceramics and synthetic bone substitutes used for antibiotic delivery in PJI and osteomyelitis treatment
- PMID: 34150324
- PMCID: PMC8183146
- DOI: 10.1302/2058-5241.6.200083
Review of calcium-sulphate-based ceramics and synthetic bone substitutes used for antibiotic delivery in PJI and osteomyelitis treatment
Abstract
Infection in orthopaedic and trauma surgery remains a destructive complication with particularly challenging diagnosis and treatment due to bacterial antibiotic resistance and biofilm formation.Along with surgical debridement and systemic antibiotics, an important type of adjuvant therapy is local antibiotic delivery, with the purpose of eliminating bacterial colonization and biofilm development.Calcium sulphate, as a synthetic absorbable biomaterial used for local antibiotic delivery, has experienced an increasing popularity during the last decade, with multiple promoted advantages such as predictable antibiotic elution kinetics, complete and quick biodegradation, good biocompatibility, and limited associated complications.A series of commercially available antibiotic-delivery systems based on calcium sulphate are under investigation and in clinical use, with different presentations, compositions, and application techniques.The current article presents the main available calcium-sulphate-based products and the existing data about the clinical and preclinical research results, stemming from their implementation as local antibiotic carriers for surgical site and implant-associated infections treatment and prevention. Cite this article: EFORT Open Rev 2021;6:297-304. DOI: 10.1302/2058-5241.6.200083.
Keywords: antibiotic delivery; biofilm; biomaterial; calcium sulphate; infection.
© 2021 The author(s).
Conflict of interest statement
ICMJE Conflict of interest statement: The authors declare no conflict of interest relevant to this work.
Figures
Similar articles
-
[Early Results of Adjuvant Topical Treatment of Recurrent Osteomyelitis with Absorbable Antibiotic Carriers].Z Orthop Unfall. 2017 Feb;155(1):35-44. doi: 10.1055/s-0042-112228. Epub 2017 Jan 12. Z Orthop Unfall. 2017. PMID: 28081583 Clinical Trial. German.
-
Ceramic Biocomposites as Biodegradable Antibiotic Carriers in the Treatment of Bone Infections.J Bone Jt Infect. 2017 Jan 1;2(1):38-51. doi: 10.7150/jbji.17234. eCollection 2017. J Bone Jt Infect. 2017. PMID: 28529863 Free PMC article. Review.
-
Bone infections and bone graft substitutes for local antibiotic therapy.Surg Technol Int. 2014 Mar;24:353-62. Surg Technol Int. 2014. PMID: 24504740 Review.
-
A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study.Bone Joint J. 2014 Jun;96-B(6):845-50. doi: 10.1302/0301-620X.96B6.33014. Bone Joint J. 2014. PMID: 24891588
-
Therapeutics and delivery vehicles for local treatment of osteomyelitis.J Orthop Res. 2020 Oct;38(10):2091-2103. doi: 10.1002/jor.24689. Epub 2020 Apr 21. J Orthop Res. 2020. PMID: 32285973 Free PMC article. Review.
Cited by
-
In Situ Application of Berberine-Loaded Liposomes on the Treatment of Osteomyelitis.ACS Omega. 2025 Feb 12;10(7):7350-7361. doi: 10.1021/acsomega.4c11198. eCollection 2025 Feb 25. ACS Omega. 2025. PMID: 40028119 Free PMC article.
-
Is long time to reimplantation a risk factor for reinfection in two-stage revision for periprosthetic infection? A systematic review of the literature.Front Surg. 2023 Feb 17;10:1113006. doi: 10.3389/fsurg.2023.1113006. eCollection 2023. Front Surg. 2023. PMID: 36874470 Free PMC article. Review.
-
Efficacy and Safety of Antibiotic Impregnated Microporous Nanohydroxyapatite Beads for Chronic Osteomyelitis Treatment: A Multicenter, Open-Label, Prospective Cohort Study.Antibiotics (Basel). 2023 Jun 15;12(6):1049. doi: 10.3390/antibiotics12061049. Antibiotics (Basel). 2023. PMID: 37370370 Free PMC article.
-
Role of Implantable Drug Delivery Devices with Dual Platform Capabilities in the Prevention and Treatment of Bacterial Osteomyelitis.Bioengineering (Basel). 2022 Feb 6;9(2):65. doi: 10.3390/bioengineering9020065. Bioengineering (Basel). 2022. PMID: 35200418 Free PMC article. Review.
-
Local Antimicrobial Therapy with Combined Aminoglycoside and Vancomycin Compared to Aminoglycoside Monotherapy in the Surgical Management of Osteomyelitis and Fracture-Related Infection.Antibiotics (Basel). 2024 Jul 27;13(8):703. doi: 10.3390/antibiotics13080703. Antibiotics (Basel). 2024. PMID: 39200003 Free PMC article.
References
-
- de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009;37:387–397. - PubMed
-
- Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008;23:984–991. - PubMed
-
- Bohl DD, Sershon RA, Fillingham YA, Della Valle CJ. Incidence, risk factors, and sources of sepsis following total joint arthroplasty. J Arthroplasty 2016;31:2875–2879.e2. - PubMed
Publication types
LinkOut - more resources
Full Text Sources